Technology Overview

The Multiple Circulating Molecule Processing and Detection Technology is a one-stop liquid biopsy solution integrating stabilization, extraction, and molecular analysis. It preserves whole blood at room temperature for up to 14 days while maintaining molecular integrity. The system simultaneously isolates cell-free DNA (cfDNA) and extracellular vesicles (EVs), cutting processing time by 50% and improving detection sensitivity by over 10-fold compared with leading international products.

Technical Superiority

1. Blood collection tube formulation preserves multiple circulating nucleic acids at room temperature for over one week while maintaining molecular stability.

2. Multiplex circulating nucleic acid extraction kit: A magnetic bead–based purification system that simultaneously isolates nucleic acids from extracellular vesicles and cell-free sources (including DNA, RNA, and miRNA). It enhances analytical 3. sensitivity and accuracy, reduces processing time by more than half compared to commercial kits, and is compatible with automated systems.

3. KRAS/BRAF molecular detection kit for colorectal cancer, based on qPCR technology, enables simultaneous detection of two key mutations with ultra-high sensitivity for low-abundance variants. It is suitable for both tissue biopsy and liquid biopsy samples.

Application

1. Applicable to cancers such as colorectal cancer, lung cancer, and breast cancer.

2. End-to-end liquid biopsy technology independently developed, including blood stabilization reagents and cell-free nucleic acid extraction kits, integrated with precision molecular diagnostic LDTS services to accelerate commercialization and clinical adoption.